正文

MACK NDA for MM-398

(2015-02-25 23:28:14) 下一个

Upcoming Milestones

Merrimack anticipates the following upcoming milestones:

  • Presentation of updated MM-398 Phase 3 NAPOLI-1 results at ASCO GI in January 2015;
  • Submission of a New Drug Application to the FDA for MM-398;
  • Announcement of top line data from the Phase 2 clinical trial of MM-111 in gastric, esophageal and gastroesophageal cancers in 2015; and
  • Initiation of a Phase 2 clinical trial of MM-141 in front line pancreatic cancer in 2015.
[ 打印 ]
[ 加入书签 ]
阅读 () ┆ 评论 (0)
评论
目前还没有任何评论
登录后才可评论.